US Pharma now developing 44 drugs/vaccines for HIV/AIDS
The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the ...
The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the ...
Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, ...
Actavis plc today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has ...
Baxter International Inc. announced today that Baxalta Incorporated will be the name of the new, publicly traded biopharmaceutical company that ...
Spectrum Pharmaceuticals ( SPPI ) announced its intention to initiate a phase III study on SPI-2012 next year. SPI-2012, Spectrum ...
Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held ...
Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the ...
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) approved use of ...
NeuroVive Pharmaceutial AB, a leading mitochondrial medicine company, has signed an exclusive global outlicensing agreement with the US biotechnology company ...
T-Bird Pharma Inc., a pharmaceutical company focused on developing premium quality medical marijuana products, is pleased to announce that its ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.